Cardinal Health (CAH) FY2016 results: revenue $121.5 billion, up 18.5% on the year
Cardinal Health Inc. (CAH) reported revenue of $121.5 billion for fiscal 2016, the year ended 30 June 2016, up 18.5% on the year before. Net income was $1.4 billion, up 17.4%, and diluted earnings per share $4.32. The figures are the company's own, from the 10-K it filed with the SEC on 12 August 2016.
Revenue
$121.5 billion
+18.5% on the year
FY2009FY2016
Operating margin
2.0%
2.1% a year earlier
FY2009FY2016
Net income
$1.4 billion
+17.4% on the year
FY2009FY2016
Diluted EPS
$4.32
+19.3% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
121,546
102,531
91,084
+18.5%
Cost of revenue
115,003
96,819
85,923
+18.8%
Gross profit
6,543
5,712
5,161
+14.5%
Gross margin
5.4%
5.6%
5.7%
Selling, general and administrative
3,648
3,240
3,028
+12.6%
Operating income
2,459
2,161
1,885
+13.8%
Operating margin
2.0%
2.1%
2.1%
Interest expense
178
141
133
+26.2%
Pre-tax income
2,276
1,967
1,798
+15.7%
Income tax
845
755
635
+11.9%
Effective tax rate
37.1%
38.4%
35.3%
Net income
1,427
1,215
1,166
+17.4%
Net margin
1.2%
1.2%
1.3%
Diluted EPS
$4.32
$3.62
$3.38
+19.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
2,971
2,540
2,524
+17.0%
Capital expenditure
465
300
249
+55.0%
Free cash flow
2,506
2,240
2,275
+11.9%
Free cash flow margin
2.1%
2.2%
2.5%
Cash from investing
-4,080
-849
-850
Cash from financing
-1,139
60.0
-710
Depreciation and amortisation
641
451
459
+42.1%
Share-based compensation
111
110
96.0
+0.9%
Buybacks
651
1,036
673
-37.2%
Dividends paid
512
460
415
+11.3%
Dividend per share
$1.55
$1.37
$1.21
+13.1%
Diluted shares, weighted
330m
335m
345m
-1.5%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
6,554
6,256
6,401
+4.8%
Non-controlling interest
17.0
0.0
n/a
Redeemable equity
117
0.0
n/a
Debt
5,539
5,492
3,972
+0.9%
Other liabilities
21,895
18,394
15,660
+19.0%
Total liabilities and equity
34,122
30,142
26,033
+13.2%
Fixed assets
1,796
1,506
1,459
+19.3%
Goodwill
7,167
5,070
4,878
+41.4%
Intangible assets
2,259
948
992
+138.3%
Investments
200
193
100
+3.6%
Cash and equivalents
2,356
4,616
2,865
-49.0%
Receivables
7,405
6,523
5,380
+13.5%
Inventory
10,615
9,211
8,266
+15.2%
Other assets
2,324
2,075
2,093
+12.0%
Total assets
34,122
30,142
26,033
+13.2%
10-K for the year ended 30 June 2016, filed 12 August 2016: the filing.